ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,393Medicare Part D Prescriptions Filled, Including Refills

Rank: 120 out of 336

$447K Total Retail Price of All Prescriptions

Rank: 167 out of 336

546 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 546 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 9,638 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
CARVEDILOL 908 735 1 13
AMLODIPINE BESYLATE 696 584 2 1
LOSARTAN POTASSIUM 545 491 3 22
GUANFACINE HCL 344 270 R 10 4 206
SPIRONOLACTONE-HCTZ 321 259 5 211
LEVOTHYROXINE SODIUM 317 263 6 7
OMEPRAZOLE 316 282 7 3
PRAVASTATIN SODIUM 295 267 8 10
LISINOPRIL 284 234 9 6
CHLORTHALIDONE 280 250 10 111
SPIRONOLACTONE 265 154 11 42
SIMVASTATIN 206 183 12 5
TORSEMIDE 204 158 13 127
CITALOPRAM HBR 201 161 14 21
BYSTOLIC 182 152 15 79
METOPROLOL SUCCINATE 173 166 16 15
EXFORGE 170 152 17 121
METFORMIN HCL ER 158 109 18 61
CRESTOR 153 127 19 25
LOSARTAN-HYDROCHLOROTHIAZIDE 150 115 20 45
DIOVAN 150 102 20 31
GABAPENTIN 148 132 22 11
PAROXETINE HCL 144 134 23 64
METFORMIN HCL 142 119 24 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 95 25 23
AMLODIPINE BESYLATE-BENAZEPRIL 109 91 26 47
LABETALOL HCL 109 81 26 194
ATORVASTATIN CALCIUM 103 95 28 14
GLIMEPIRIDE 102 90 29 29
ALLOPURINOL 102 85 29 30
LANTUS 99 85 31 56
BENAZEPRIL HCL 98 77 32 59
VERAPAMIL ER 92 88 33 95
HYDRALAZINE HCL 89 78 34 53
DOXAZOSIN MESYLATE 87 63 35 86
HYDROCODONE-ACETAMINOPHEN 85 80 S3 36 2
FLUTICASONE PROPIONATE 85 74 36 49
SYNTHROID 83 62 38 43
AMITRIPTYLINE HCL 81 69 R 39 57
ISOSORBIDE MONONITRATE ER 81 73 39 44
FENOFIBRATE 74 73 41 72
ZOLPIDEM TARTRATE 73 66 42 18
TRAMADOL HCL 73 70 42 20
TRAMADOL HCL-ACETAMINOPHEN 70 70 44 148
PANTOPRAZOLE SODIUM 69 63 45 40
CLOPIDOGREL 67 62 46 28
TAMSULOSIN HCL 67 67 46 38
DIOVAN HCT 66 49 48 41
MELOXICAM 65 53 49 19
FUROSEMIDE 63 54 50 4
TRAZODONE HCL 62 62 51 46
POTASSIUM CHLORIDE 60 32 52 9
TRIAMTERENE-HCTZ 59 59 53 35
MINOXIDIL 59 48 53 269
NEXIUM 51 51 55 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.